Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents

Bioorganic & Medicinal Chemistry
2009.0

Abstract

A series of novel acylpiperazinyl Ligustrazine derivatives was designed, synthesized, and their protective effects on damaged ECV-304 cells and antiplatelet aggregation activities were evaluated. The results showed that compound E33 displayed most potential protective effects on the ECV-304 cells damaged by hydrogen peroxide, and compound E1 was found to be the most active antiplatelet aggregation agent. Structure-activity relationships were briefly discussed.

Knowledge Graph

Similar Paper

Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents
Bioorganic & Medicinal Chemistry 2009.0
Design, synthesis, and biological activities of novel Ligustrazine derivatives
Bioorganic & Medicinal Chemistry 2007.0
Ligustrazine derivatives. Part 5: Design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents
European Journal of Medicinal Chemistry 2011.0
Design, synthesis and biological evaluation of novel ligustrazinylated derivatives as potent cardiovascular agents
MedChemComm 2013.0
Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives
European Journal of Medicinal Chemistry 2018.0
Design, synthesis and biological evaluation of novel trimethylpyrazine-2-carbonyloxy-cinnamic acids as potent cardiovascular agents
MedChemComm 2014.0
Synthesis of the novel liqustrazine derivatives and Their protective effect on injured vascular endothelial cell damaged by hydrogen peroxide
Bioorganic & Medicinal Chemistry Letters 2003.0
Nucleoside alkaloids with anti-platelet aggregation activity from the rhizomes of Ligusticum striatum
Natural Product Research 2019.0
Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation
European Journal of Medicinal Chemistry 2013.0
6-Aryl-4,5-dihydro-3(2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities
Journal of Medicinal Chemistry 1983.0